188 related articles for article (PubMed ID: 20203097)
1. Plasma Pentraxin 3, but not high-sensitivity C-reactive protein, is a useful inflammatory biomarker for predicting cognitive impairment in elderly hypertensive patients.
Yano Y; Matsuda S; Hatakeyama K; Sato Y; Imamura T; Shimada K; Kodama T; Kario K; Asada Y
J Gerontol A Biol Sci Med Sci; 2010 May; 65(5):547-52. PubMed ID: 20203097
[TBL] [Abstract][Full Text] [Related]
2. Pentraxin 3 (PTX3) is associated with cardiovascular risk factors: the Health 2000 Survey.
Jylhävä J; Haarala A; Kähönen M; Lehtimäki T; Jula A; Moilanen L; Kesäniemi YA; Nieminen MS; Hurme M
Clin Exp Immunol; 2011 May; 164(2):211-7. PubMed ID: 21391986
[TBL] [Abstract][Full Text] [Related]
3. Elevated pentraxin-3 levels are related to blood pressure levels in hypertensive patients: an observational study.
Parlak A; Aydoğan U; Iyisoy A; Dikililer MA; Kut A; Cakır E; Sağlam K
Anadolu Kardiyol Derg; 2012 Jun; 12(4):298-304. PubMed ID: 22466361
[TBL] [Abstract][Full Text] [Related]
4. Plasma pentraxin 3 is associated with cardiovascular disease in hemodialysis patients.
Xu Y; Ding X; Zou J; Liu Z; Jiang S; Xu S; Shen B; Chen Y; Shan Y; Cao X
Ren Fail; 2011; 33(10):998-1004. PubMed ID: 22013933
[TBL] [Abstract][Full Text] [Related]
5. Gastric bypass-induced weight loss alters obesity-associated patterns of plasma pentraxin-3 and systemic inflammatory markers.
Barazzoni R; Palmisano S; Gortan Cappellari G; Giuricin M; Moretti E; Vinci P; Semolic A; Guarnieri G; Zanetti M; Manzini Nd
Surg Obes Relat Dis; 2016 Jan; 12(1):23-32. PubMed ID: 26277450
[TBL] [Abstract][Full Text] [Related]
6. Serum high sensitivity C-reactive protein and cognitive function in elderly women.
Komulainen P; Lakka TA; Kivipelto M; Hassinen M; Penttilä IM; Helkala EL; Gylling H; Nissinen A; Rauramaa R
Age Ageing; 2007 Jul; 36(4):443-8. PubMed ID: 17537742
[TBL] [Abstract][Full Text] [Related]
7. Elevated concentrations of pentraxin 3 are associated with coronary plaque vulnerability.
Soeki T; Niki T; Kusunose K; Bando S; Hirata Y; Tomita N; Yamaguchi K; Koshiba K; Yagi S; Taketani Y; Iwase T; Yamada H; Wakatsuki T; Akaike M; Sata M
J Cardiol; 2011 Sep; 58(2):151-7. PubMed ID: 21676590
[TBL] [Abstract][Full Text] [Related]
8. Determination of physiological plasma pentraxin 3 (PTX3) levels in healthy populations.
Yamasaki K; Kurimura M; Kasai T; Sagara M; Kodama T; Inoue K
Clin Chem Lab Med; 2009; 47(4):471-7. PubMed ID: 19327124
[TBL] [Abstract][Full Text] [Related]
9. The effect of candesartan on pentraxin-3 plasma levels as marker of endothelial dysfunction in patients with essential arterial hypertension.
Buda V; Andor M; Cristescu C; Voicu M; Cochera F; Tuduce P; Petrescu L; Tomescu MC
Ir J Med Sci; 2017 Aug; 186(3):621-629. PubMed ID: 28220370
[TBL] [Abstract][Full Text] [Related]
10. Plasma C-reactive protein is related to cognitive deterioration and dementia in patients with mild cognitive impairment.
Xu G; Zhou Z; Zhu W; Fan X; Liu X
J Neurol Sci; 2009 Sep; 284(1-2):77-80. PubMed ID: 19419739
[TBL] [Abstract][Full Text] [Related]
11. Is pentraxin 3 involved in obesity-induced decrease in arterial distensibility?
Miyaki A; Maeda S; Yoshizawa M; Misono M; Sasai H; Shimojo N; Tanaka K; Ajisaka R
J Atheroscler Thromb; 2010 Mar; 17(3):278-84. PubMed ID: 20134101
[TBL] [Abstract][Full Text] [Related]
12. Plasma des-acyl ghrelin, but not plasma HMW adiponectin, is a useful cardiometabolic marker for predicting atherosclerosis in elderly hypertensive patients.
Yano Y; Toshinai K; Inokuchi T; Kangawa K; Shimada K; Kario K; Nakazato M
Atherosclerosis; 2009 Jun; 204(2):590-4. PubMed ID: 19041092
[TBL] [Abstract][Full Text] [Related]
13. The Evaluation of Serum Pentraxin-3 and High-Sensitivity C-Reactive Protein Levels in Patients with Acute Attack of COPD.
Duran L; Unsal M; Yardan T; Kati C; Bedir A; Turkeli S; Ekiz M
Clin Lab; 2015; 61(12):1911-6. PubMed ID: 26882815
[TBL] [Abstract][Full Text] [Related]
14. Plasma pentraxin 3 may be a more sensitive marker of inflammatory response than high-sensitivity C-reactive protein after bare-metal stent compared to drug-eluting stent implantation.
Hudzik B; Szkodzinski J; Pietka-Rzycka A; Danikiewicz A; Wojnar R; Lekston A; Polonski L; Zubelewicz-Szkodzinska B
J Interferon Cytokine Res; 2013 May; 33(5):280-4. PubMed ID: 23414296
[TBL] [Abstract][Full Text] [Related]
15. Plasma pentraxin 3 is associated with progression of radiographic joint damage, but not carotid atherosclerosis, in female rheumatoid arthritis patients: 3-year prospective study.
Asanuma YF; Aizaki Y; Noma H; Yokota K; Matsuda M; Kozu N; Takebayashi Y; Nakatani H; Hasunuma T; Kawai S; Mimura T
Mod Rheumatol; 2020 Nov; 30(6):959-966. PubMed ID: 31615315
[No Abstract] [Full Text] [Related]
16. Clinical value of plasma pentraxin 3 levels for predicting cardiac troponin elevation after percutaneous coronary intervention.
Wang Z; Sato A; Akiyama D; Kimura T; Tajiri K; Hoshi T; Sakai S; Koike A; Miyauchi T; Aonuma K
Life Sci; 2014 Jan; 95(1):40-4. PubMed ID: 24333560
[TBL] [Abstract][Full Text] [Related]
17. The role of pentraxin-3 as a prognostic biomarker in paraquat poisoning.
Yeo CD; Kim JW; Kim YO; Yoon SA; Kim KH; Kim YS
Toxicol Lett; 2012 Jul; 212(2):157-60. PubMed ID: 22210019
[TBL] [Abstract][Full Text] [Related]
18. Plasma long pentraxin 3 (PTX3) concentration is a novel marker of disease activity in patients with community-acquired pneumonia.
Kao SJ; Yang HW; Tsao SM; Cheng CW; Bien MY; Yu MC; Bai KJ; Yang SF; Chien MH
Clin Chem Lab Med; 2013 Apr; 51(4):907-13. PubMed ID: 23152412
[TBL] [Abstract][Full Text] [Related]
19. Circulating pentraxin 3 levels are higher in metabolic syndrome with subclinical atherosclerosis: evidence for association with atherogenic lipid profile.
Zanetti M; Bosutti A; Ferreira C; Vinci P; Biolo G; Fonda M; Valente M; Cattin L; Guarnieri G; Barazzoni R
Clin Exp Med; 2009 Sep; 9(3):243-8. PubMed ID: 19238513
[TBL] [Abstract][Full Text] [Related]
20. Inflammatory biomarker pentraxin 3 (PTX3) in relation to obesity, body fat depots and weight loss.
Witasp A; Carrero JJ; Michaëlsson K; Ahlström H; Kullberg J; Adamsson V; Risérus U; Larsson A; Helmersson-Karlqvist J; Lind L; Stenvinkel P; Arnlöv J
Obesity (Silver Spring); 2014 May; 22(5):1373-9. PubMed ID: 24415446
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
